1-5 of 5
Yao Dai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B59: Dual mTOR kinase inhibitor reverses rapamycin resistance in prostate cancer cells

Free
Yao Dai, Li Zhao, Dietmar W. Siemann
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): B59.
https://doi.org/10.1158/1535-7163.TARG-15-B59
Published: 01 December 2015
View articletitled, Abstract B59: Dual mTOR kinase inhibitor reverses rapamycin resistance in prostate cancer cells
Journal Articles

BMS-777607, a Small-Molecule Met Kinase Inhibitor, Suppresses Hepatocyte Growth Factor–Stimulated Prostate Cancer Metastatic Phenotype In vitro

Free
Yao Dai, Dietmar W. Siemann
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1554–1561.
https://doi.org/10.1158/1535-7163.MCT-10-0359
Published: 09 June 2010
View articletitled, BMS-777607, a Small-Molecule Met Kinase Inhibitor, Suppresses Hepatocyte Growth Factor–Stimulated Prostate Cancer Metastatic Phenotype In vitro
Open the PDF for BMS-777607, a Small-Molecule Met Kinase Inhibitor, Suppresses Hepatocyte Growth Factor–Stimulated Prostate Cancer Metastatic Phenotype In vitro in another window
Journal Articles

Abstract C190: BMS‐777607, a potent small molecule c‐MET inhibitor, inhibits prostate cancer progression in vitro

Free
Yao Dai, Dietmar Siemann
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C190.
https://doi.org/10.1158/1535-7163.TARG-09-C190
Published: 10 December 2009
View articletitled, Abstract C190: BMS‐777607, a potent small molecule c‐MET inhibitor, inhibits prostate cancer progression in vitro
Journal Articles

Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa

Free
Yang Meng, Wenhua Tang, Yao Dai, Xiaoqing Wu, Meilan Liu, Qing Ji, Min Ji, Kenneth Pienta, Theodore Lawrence, Liang Xu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (7): 2192–2202.
https://doi.org/10.1158/1535-7163.MCT-08-0333
Published: 21 July 2008
View articletitled, Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa
Open the PDF for Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa in another window
Includes: Supplementary data
Journal Articles

Molecular radiosensitization of prostate cancer by modulating cell death pathways

Free
Liang Xu, Yao Dai, Yang Meng, Wenhua Tang, Qing Ji, Min Zhang, Xinbao Hao, Kenneth Pienta, Theodore Lawrence
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A120.
Published: 01 November 2007
View articletitled, Molecular radiosensitization of prostate cancer by modulating cell death pathways